Resource id #3DrugId:2d00000005resource(4) of type (mysql result) Drug Search

Main    A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    Main   


Drug ID: 2d00000005

Drug Name: Balsalazide

Generic Names: Colorex | Intazide | Balacol | Cozabal | Colazal

Category: Anti- Inflammatory Agents

Legal Status: Non Opioid Prescription only drug

OTC: No

Indication for Mother: Category B
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Recommended Dose: Adult: Acute attack: 2.25 g 3 times/day, until remission or up to 12 week. Max: 6.75 g/day.

Maintenance: 1.5 g twice daily. Max: 6 g/day.

Recommended In: This medication is an anti-inflammatory agent, prescribed for ulcerative colitis. The medication reduces inflammation of colon.

Directions For Use: It comes as a capsule and syrup to take by mouth with food.

Storage: Store it at room temperature (25C).

Dosage Forms: Capsule | Syrup

Side Effects: Most Common- Headache, abdominal pain, diarrhea, nausea, vomiting, respiratory tract infection and joint pain.

Respiratory- Cough and inflammation of nose.

Gastrointestinal- Indigestion, loss of appetite, dry mouth, abdominal cramps, constipation and flatulence.

Central Nervous System- Sleeplessness and fatigue.

Miscellaneous- Fever, flu-like syndrome, urinary tract syndrome and muscle pain.

In Case of Overdose: If an overdose occurs with COLAZAL (balsalazide) , treatment should be supportive, with particular attention to correction of electrolyte abnormalities. Activated charcoal or ipecac can be given as antidote.

Avoid If: Caution should be exercised in patients with history of liver or kidney impairment, blood disorders; during pregnancy and lactation.

Take full course of treatment.

Drug Interaction: No significant drug interactions are observed yet.



Main    A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    Main